-
Sarepta plans to seek full FDA approval of 2 Duchenne treatments
Sarepta Therapeutics plans to ask the U.S. Food and Drug Administration (FDA) to grant full
-
PPMD Provides $250,000 in Funding to Secretome Therapeutics Through PPMD Venture Pathways Program to Support Development of Cardiac Cell Therapy
PPMD and Secretome Therapeutics (Secretome) are excited to announce that PPMD has provided $250,000 in








